Casandra
Casandra Test Code QD61599Version 1 (DRAFT)
Performing Lab
CSF3R Mutation Analysis
Also known as: Myeloproliferative neoplasm, CNL, Atypical Chronic Myeloid Leukemia (aCML), aCML, Chronic Neutrophilic Leukemia (CNL)
Clinical Use
Order TestUse
This advanced DNA‑based, next‑generation sequencing (NGS) assay analyzes leukocytes from blood or bone marrow aspirate for mutations in exons 14 and 17 of colony stimulating factor 3 receptor (CSF3R). Mutations in these two regions of CSF3R are associated with myeloid neoplasms, particularly atypical chronic myeloid leukemia (aCML) and chronic neutrophilic leukemia (CNL).
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
NGS (Targeted)
Biomarkers
CSF3R
GeneSNV/Indel
Mutation • Categorical (e.g., Positive / Negative / Indeterminate)
Result Turnaround Time
5-7 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
4 mL
Minimum Volume
3 mL
Container
EDTA (lavender‑top) tube
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 7 days |
| Frozen | Unacceptable |
Similar Tests
Other tests from different labs that may be relevant
CSF3R Mutation Analysis
NeoGenomics
Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing
ARUP Laboratories
Myeloid Malignancies Mutation Panel by Next Generation Sequencing
ARUP Laboratories
NeoTYPE® MDS/CMML Profile
NeoGenomics
Neo Comprehensive - Myeloid Disorders
NeoGenomics
CML FISH Reflex to JAK2V617F Mutation Analysis, Quantitative, With Reflex to CALR Mutation Analysis, JAK2 Exon 12-15 Mutation Analysis and MPL Mutation Analysis by NGS
Labcorp
IntelliGEN® Myeloid
Labcorp
Acute Myeloid Leukemia Mutation Panel by Next Generation Sequencing
ARUP Laboratories
c-KIT Mutation Analysis in Tumors of Hematopoietic Tissue
Labcorp
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance by Next Generation Sequencing
ARUP Laboratories